ArticleMolecular therapy. Nucleic acids2026

Rational design of hammerhead ribozymes as CD93 silencing tools for vascular diseases.

Cosimo Damiano Perrone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.